Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: A 20-year follow-up study in Thailand

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 8, 2013, Pages 1679-1684

  Poovorawan, Yong ^a   Chongsrisawat, Voranush ^a   Theamboonlers, Apiradee ^a   Crasta, Priya Diana ^b   Messier, Marc ^c   Hardt, Karin ^d  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b GlaxoSmithKline Pharmaceuticals Ltd   (India)

^c BioMed Trials   (Belgium)

^d GSK   (Belgium)

Author keywords

Challenge dose; Hepatitis B; Hepatitis B virus; Persistence; Vaccine

Indexed keywords

RECOMBINANT HEPATITIS B VACCINE;

ACTIVE IMMUNIZATION; ADULT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; DRUG SAFETY; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; IMMUNOGENICITY; IMMUNOLOGICAL MEMORY; MALE; THAILAND; UNSPECIFIED SIDE EFFECT;

CHALLENGE DOSE; HEPATITIS B; HEPATITIS B VIRUS; PERSISTENCE; VACCINE;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNOLOGIC MEMORY; INFANT; INFANT, NEWBORN; MALE; THAILAND; TIME FACTORS; VACCINATION; YOUNG ADULT;

EID: 84883038873     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.24844     Document Type: Article

References (26)

1. World Health Organization. Hepatitis B Vaccines. Wkly Epidemiol Rec 2009; 84:405-20. Available at: http://www.who.int/wer. Last accessed 26 February 2013.
2. Heron L, Selnikova O, Moiseieva A, Van Damme P, van der Wielen M, Levie K, et al. Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial. Vaccine 2007; 25:2817-22; PMID:17276552; http://dx.doi.org/10.1016/j.vaccine.2006.12.021
3. Centers for Disease Control and Prevention (CDC). Global progress toward universal childhood hepatitis B vaccination, 2003. MMWR Morb Mortal Wkly Rep 2003; 52:868-70; PMID:12970620
4. Ni YH, Chang MH, Huang LM, Chen HL, Hsu HY, Chiu TY, et al. Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination. Ann Intern Med 2001; 135:796-800; PMID:11694104; http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00009
5. Chang MH, Chen CJ, Lai MS, Hsu HM, Wu TC, Kong MS, et al.; Taiwan Childhood Hepatoma Study Group. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N Engl J Med 1997; 336:1855-9; PMID:9197213; http://dx.doi.org/10.1056/NEJM199706263362602
6. Chongsrisawat V, Yoocharoen P, Theamboonlers A, Tharmaphornpilas P, Warinsathien P, Sinlaparatsamee S, et al. Hepatitis B seroprevalence in Thailand: 12 years after hepatitis B vaccine integration into the national expanded programme on immunization. Trop Med Int Health 2006; 11:1496-502; PMID:17002723; http://dx.doi.org/10.1111/j.1365-3156.2006.01709.x
7. FitzSimons D, François G, Emiroǧlu N, Van Damme P. Combined hepatitis B vaccines. Vaccine 2003; 21:1310-6; PMID:12615425; http://dx.doi.org/10.1016/S0264-410X(02)00636-9
8. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Bock HL, Leyssen M, Jacquet JM. Persistence of antibodies and immune memory to hepatitis B vaccine 20 years after infant vaccination in Thailand. Vaccine 2010; 28:730-6; PMID:19892043; http://dx.doi.org/10.1016/j.vaccine.2009.10.074
9. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Crasta PD, Hardt K. Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers. Hum Vaccin Immunother 2012; 8:896-904; PMID:22777097; http://dx.doi.org/10.4161/ hv.19989
10. Sa-Nguanmoo P, Tangkijvanich P, Tharmaphornpilas P, Rasdjarmrearnsook AO, Plianpanich S, Thawornsuk N, et al. Molecular analysis of hepatitis B virus associated with vaccine failure in infants and mothers: a case-control study in Thailand. J Med Virol 2012; 84:1177-85; PMID:22711345; http://dx.doi.org/10. 1002/jmv.23260
11. Poovorawan Y, Chongsrisawat V, Theamboonlers A, Leroux-Roels G, Kuriyakose S, Leyssen M, et al. Evidence of protection against clinical and chronic hepatitis B infection 20 years after infant vaccination in a high endemicity region. J Viral Hepat 2011; 18:369-75; PMID:20384962; http://dx.doi.org/10.1111/j.1365-2893.2010.01312.x
12. Poovorawan Y, Sanpavat S, Pongpunglert W, Chumdermpadetsuk S, Sentrakul P, Vandepapelière P, et al. Long term efficacy of hepatitis B vaccine in infants born to hepatitis B e antigen-positive mothers. Pediatr Infect Dis J 1992; 11:816-21; PMID:1408478; http://dx.doi.org/10.1097/00006454-199210000- 00002
13. Poovorawan Y, Sanpavat S, Chumdermpadetsuk S, Safary A. Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers. Arch Dis Child Fetal Neonatal Ed 1997; 77:F47-51; PMID:9279183; http://dx.doi.org/10.1136/fn.77.1.F47
14. Chinchai T, Chirathaworn C, Praianantathavorn K, Theamboonlers A, Hutagalung Y, Bock PH, et al. Long-term humoral and cellular immune response to hepatitis B vaccine in high-risk children 18-20 years after neonatal immunization. Viral Immunol 2009; 22:125-30; PMID:19326999; http://dx.doi.org/ 10.1089/vim.2008.0087
15. Bialek SR, Bower WA, Novak R, Helgenberger L, Auerbach SB, Williams IT, et al. Persistence of protection against hepatitis B virus infection among adolescents vaccinated with recombinant hepatitis B vaccine beginning at birth: a 15-year follow-up study. Pediatr Infect Dis J 2008; 27:881-5; PMID:18756185; http://dx.doi.org/10.1097/INF.0b013e31817702ba
16. Hammitt LL, Hennessy TW, Fiore AE, Zanis C, Hummel KB, Dunaway E, et al. Hepatitis B immunity in children vaccinated with recombinant hepatitis B vaccine beginning at birth: a follow-up study at 15 years. Vaccine 2007; 25:6958-64; PMID:17714836; http://dx.doi.org/10.1016/j.vaccine.2007.06.059
17. Schönberger K, Riedel C, Rückinger S, Mansmann U, Jilg W, Kries RV. Determinants of Long Term Protection after Hepatitis B Vaccination in Infancy: A Meta-Analysis. Pediatr Infect Dis J 2013; 32:307-13; PMID:23249904
18. Lu CY, Chiang BL, Chi WK, Chang MH, Ni YH, Hsu HM, et al. Waning immunity to plasma-derived hepatitis B vaccine and the need for boosters 15 years after neonatal vaccination. Hepatology 2004; 40:1415-20; PMID:15565627; http://dx.doi.org/10.1002/hep.20490
19. Mele A, Tancredi F, Romanò L, Giuseppone A, Colucci M, Sangiuolo A, et al. Effectiveness of hepatitis B vaccination in babies born to hepatitis B surface antigen-positive mothers in Italy. J Infect Dis 2001; 184:905-8; PMID:11509998; http://dx.doi.org/10.1086/323396
20. Banatvala JE, Van Damme P. Hepatitis B vaccine-do we need boosters? J Hepatol 2003; 10:1-6
21. Fitzsimons D, François G, Hall A, McMahon B, Meheus A, Zanetti A, et al. Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants. Vaccine 2005; 23:4158-66; PMID:15964484; http://dx.doi.org/10.1016/j.vac-cine.2005.03.017
22. Van Damme P, Ward J, Shouval D, Wiersma S, Zanetti A. Hepatitis B vaccines. In: Plotkin SA, ed. Vaccines. 6th ed. Doylestown, PA: Elsevier Saunders, 2012.
23. American Academy of Pediatrics. Hepatitis B. In: Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red Book: 2006 Report of the Committee on Infectious Diseases. 27th ed. Elk Grove Village, IL: American Academy of Pediatrics, 2006:343-4.
24. Dentinger CM, McMahon BJ, Butler JC, Dunaway CE, Zanis CL, Bulkow LR, et al. Persistence of antibody to hepatitis B and protection from disease among Alaska natives immunized at birth. Pediatr Infect Dis J 2005; 24:786-92; PMID:16148845; http://dx.doi.org/10.1097/01.inf.0000176617.63457.9f
25. van der Sande MA, Waight P, Mendy M, Rayco-Solon P, Hutt P, Fulford T, et al. Long-term protection against carriage of hepatitis B virus after infant vaccination. J Infect Dis 2006; 193:1528-35; PMID:16652281; http://dx.doi.org/ 10.1086/503433
26. Noborg U, Gusdal A, Pisa EK, Hedrum A, Lindh M. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV monitor test. J Clin Microbiol 1999; 37:2793-7; PMID:10449454